
![]() |
|||||||||||||
WJPR Citation Report
|
| All | Since 2021 | |
| Citation | 9186 | 4781 |
| h-index | 32 | 25 |
| i10-index | 256 | 108 |
THE ROLE OF ACTIVE PHARMACEUTICAL INGREDIENTS IN FORMULATION STRATEGIES FOR CHOLESTEROL-LOWERING MEDICATIONS
Dr. Payal N. Vaja*, Prof. Hiral S. Popaniya, Ms. Siddhi K. Upadhyay, Mr. Harsh H. Madiya, Mr. Dilip R. Ghusar, Mr. Vivek P. Sonaki, Dr. Chetan H. Borkhataria
Abstract Background: Cholesterol is a critical lipid required for various physiological functions, yet imbalances between high-density lipoprotein (HDL) and low-density lipoprotein (LDL) can lead to significant cardiovascular issues. Objective: This review aims to explore the role of active ingredients in the formulation strategies of cholesterol-lowering medications, focusing on their mechanisms of action, efficacy, and formulation considerations. Methods: A comprehensive literature review was conducted, analyzing various classes of anti- hyperlipidaemic drugs, including statins, bile acid sequestrants, and fibrates. The review highlights the chemical structures, pharmacological properties, and clinical implications of these active pharmaceutical ingredients (APIs). Discussions: The findings emphasize the importance of selecting appropriate active ingredients and formulation strategies to enhance drug efficacy, patient adherence, and overall treatment outcomes in managing hyperlipidaemia. Keywords: Cholesterol, Anti-hyperlipidaemic drugs, Lipid management, Atorvastatin, Rosuvastatin. [Full Text Article] [Download Certificate] |
